Citation: A. Cecchi et R. Di Marco, Homogenization of FRP pultruded elements: a computational procedure for designing composite materials, MATER STRUC, 34(240), 2001, pp. 378-384
Authors:
Di Marco, R
Puglisi, G
Papaccio, G
Nicoletti, A
Patti, F
Reggio, A
Bendtzen, K
Nicoletti, F
Citation: R. Di Marco et al., Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat, MULT SCLER, 7(2), 2001, pp. 101-104
Authors:
Di Marco, R
Khademi, M
Wallstrom, E
Iacobaeus, E
Salvaggio, A
Caracappa, S
Papoian, R
Nicoletti, F
Olsson, T
Citation: R. Di Marco et al., Curative effects of recombinant human interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis, J NEUROIMM, 116(2), 2001, pp. 168-177
Authors:
Nicoletti, F
Di Marco, R
Sacerdote, P
Meroni, P
Mangano, K
Edwards, C
Bartorelli, A
Bendtzen, K
Panerai, A
Citation: F. Nicoletti et al., Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14, ANTIM AG CH, 45(5), 2001, pp. 1591-1594
Authors:
Nicoletti, F
Conget, I
Di Marco, R
Speciale, AM
Moringo, R
Bendtzen, K
Gomis, R
Citation: F. Nicoletti et al., Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes, DIABETOLOG, 44(3), 2001, pp. 309-311
Authors:
Nicoletti, F
Di Marco, R
Patti, F
Zaccone, P
L'Episcopo, MR
Reggio, E
Xiang, M
Nicoletti, A
Reggio, A
Citation: F. Nicoletti et al., Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)beta 1b transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1 beta, IL-2, IL-4 and tumour necrosis factor-alpha, CYTOKINE, 12(6), 2000, pp. 682-687
Authors:
Nicoletti, F
Zaccone, P
Xiang, M
Magro, G
Di Mauro, M
Di Marco, R
Garotta, G
Meroni, P
Citation: F. Nicoletti et al., Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: Exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein, CYTOKINE, 12(4), 2000, pp. 315-323
Citation: A. Cecchi et R. Di Marco, Homogenization of masonry walls with a computational oriented procedure. Rigid or elastic block?, EUR J MEC A, 19(3), 2000, pp. 535-546
Authors:
Nicoletti, F
Di Marco, R
Conget, I
Gomis, R
Edwards, C
Papaccio, G
Bendtzen, K
Sandler, S
Citation: F. Nicoletti et al., Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin, J AUTOIMMUN, 15(4), 2000, pp. 395-405
Authors:
Nicoletti, F
Di Marco, R
Patti, F
Nicoletti, A
Leonardi, C
Reggio, E
Meroni, P
Reggio, A
Citation: F. Nicoletti et al., The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells, AUTOIMMUN, 32(4), 2000, pp. 265-270
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Salvaggio, A
Magro, G
Bendtzen, K
Meroni, P
Citation: F. Nicoletti et al., Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism, HEPATOLOGY, 32(4), 2000, pp. 728-733
Authors:
Khademi, M
Wallstrom, E
Andersson, M
Piehl, F
Di Marco, R
Olsson, T
Citation: M. Khademi et al., Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis, J NEUROIMM, 103(2), 2000, pp. 202-210
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Xiang, M
Magro, G
Grasso, S
Morrone, S
Santoni, A
Shoenfeld, Y
Garotta, G
Meroni, P
Citation: F. Nicoletti et al., Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice, EUR J IMMUN, 30(2), 2000, pp. 438-447
Authors:
Di Marco, R
Khademi, M
Wallstrom, E
Muhallab, S
Nicoletti, F
Olsson, T
Citation: R. Di Marco et al., Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10, J AUTOIMMUN, 13(2), 1999, pp. 187-195
Authors:
Di Marco, R
Xiang, M
Zaccone, P
Leonardi, C
Franco, S
Meroni, P
Nicoletti, F
Citation: R. Di Marco et al., Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency, AUTOIMMUN, 31(2), 1999, pp. 75-83
Authors:
Xiang, M
Zaccone, P
Di Marco, R
Harris, R
Magro, G
Di Mauro, M
Meroni, PL
Garotta, G
Nicoletti, F
Citation: M. Xiang et al., Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice, AUTOIMMUN, 30(2), 1999, pp. 71-80
Authors:
Malaguarnera, M
Restuccia, S
Di Fazio, I
Di Marco, R
Pistone, G
Trovato, BA
Citation: M. Malaguarnera et al., Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment, PANMIN MED, 41(1), 1999, pp. 59-61
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Magro, G
Di Mauro, M
Grasso, S
Meroni, PL
Citation: F. Nicoletti et al., Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease, IMMUNOLOGY, 97(3), 1999, pp. 367-370
Authors:
Xiang, M
Zaccone, P
Di Marco, R
Magro, G
Di Mauro, M
Beltrami, B
Meroni, PL
Nicoletti, F
Citation: M. Xiang et al., Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice, EUR J PHARM, 367(2-3), 1999, pp. 399-404